Results 61 to 70 of about 13,203 (228)

Supplementary Material for: Distinctive Olfactory Pattern in Parkinson’s Disease and Non-Neurodegenerative Causes of Hyposmia

open access: yes, 2018
Background: Olfactory dysfunction is common in Parkinson’s disease (PD). The characteristics of the hyposmia in PD have not been well defined. Objective: To characterize the pattern of the olfactory deficit in PD and in other non-neurodegenerative ...
Crespo Cuevas A.M. (5438348)   +7 more
core   +2 more sources

Olfactory Dysfunction, an Often Neglected Symptom of Hydrocephalus: Experience from a Case of Late-Onset Idiopathic Aqueductal Stenosis

open access: yesCase Reports in Neurology, 2023
Disturbance of smell is often accompanied with common neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases. In addition, patients with head trauma, intracranial tumors, and hydrocephalus can also develop olfactory dysfunction, and some
Naoya Yamazaki   +8 more
doaj   +1 more source

Goofy/123Cre lineage tracing differentiates olfactory and vomeronasal neurons from GnRH‐1 and terminal nerve neurons during neuronal migration and reveals additional olfactory placode‐derived cells in the brain

open access: yesDevelopmental Dynamics, EarlyView.
Abstract The olfactory placode (OP) generates a broad array of chemosensory neurons in the nasal region, including olfactory sensory neurons, vomeronasal sensory neurons, neurons of the septal organ, and Grueneberg ganglion. During invagination, the OP also generates migratory neuronal populations, including gonadotropin‐releasing hormone‐1 (GnRH‐1 ...
Enrico Amato Jr.   +5 more
wiley   +1 more source

Olfactory Dysfunction in COVID-19 Patients in a Tertiary Care Hospital; A Cross-Sectional Observational Study [PDF]

open access: yesIranian Journal of Otorhinolaryngology
Introduction: Sudden onset of olfactory dysfunction (OD) manifesting as hyposmia and/or anosmia occurred in many COVID-19 patients, with a frequency as high as 85.6%.
Sreedevi Thippeswamy, Kamalesh Nataraju
doaj   +1 more source

Hyposmia in COVID-19: Temporal Recovery of Smell: A Preliminary Study

open access: yesMedicina, 2023
Background and Objectives: Hypo/anosmia is a characteristic symptom of COVID-19 infection. The aim of this study is to investigate the time of smell recovery and to identify a possible order of perception recovery of different odors in COVID-19 patients.
Barbara Verro   +2 more
doaj   +1 more source

Olfactory Training and Oral CorticosteroidTherapy for Persistent Postinfectious Hyposmia [PDF]

open access: yes
Introduction Postinfectious hyposmia gained special attention in the postpandemic era, and persistent cases are particularly difficult to treat. Many unproven therapies are used in clinical practice, including corticosteroids, with insufficient evidence.
Dantas Costa Lima Godoy, Maria   +6 more
core   +1 more source

Mechanism of RNA‐Binding Protein ELAVL1 in Promoting Th2 Cell Differentiation Through Stabilizing CPA3 mRNA in Allergic Rhinitis

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study aimed to elucidate the role of the RNA‐binding protein embryonic lethality abnormal vision‐like protein 1 (ELAVL1) in the pathogenesis of allergic rhinitis (AR), specifically by investigating its potential to promote T helper 2 (Th2) cell differentiation by regulating the stability of carboxypeptidase A3 (CPA3) mRNA.
Meng‐Ya Liu   +2 more
wiley   +1 more source

Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review

open access: yesFrontiers in Neuroscience
Neurodegenerative diseases represent a group of disorders characterized by progressive degeneration of neurons in the central nervous system, leading to a range of cognitive, motor, and sensory impairments.
Nicolas De Cleene   +6 more
doaj   +1 more source

N1 and P1 Components Associate With Visuospatial-Executive and Language Functions in Normosmic Parkinson’s Disease: An Event-Related Potential Study

open access: yesFrontiers in Aging Neuroscience, 2019
Background: Hyposmia is one of the most important clinical markers of Parkinson’s disease (PD) with a prevalence ranging from 50 to 96% of PD patients. A significant association was found between hyposmia and cognitive impairment of PD.
Yi-Qi Lin   +10 more
doaj   +1 more source

Acute Hyposmia in Type 2 Diabetes

open access: yesJournal of International Medical Research, 2003
During treatment for type 2 diabetes with a diabetic diet (without medication), a 61-year-old Japanese man suddenly developed hyposmia. The fasting plasma glucose was 208 mg/dl and haemoglobin A 1c was 8.6%.
S, Takayama, T, Sasaki
openaire   +2 more sources

Home - About - Disclaimer - Privacy